Dr. Alison Moskowitz, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Lymphoma
Studies Relapse
12 reported clinical trials
20 drugs studied
Area of expertise
1Lymphoma
Stage I
Stage III
Stage IV
2Relapse
Stage I
Affiliated Hospitals
Clinical Trials Alison Moskowitz, MD is currently running
Ruxolitinib + Duvelisib
for Lymphoma
This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on people with relapsed or refractory NK-cell or T-cell lymphoma. This study has three parts: dose escalation (Part 1), dose expansion (Part 2), and TFH/T-PLL cohort expansion (Part 3).
Recruiting1 award Phase 1
Brentuximab Vedotin
for Cutaneous T-Cell Lymphoma
The purpose of this study is to test any good and bad effects of the study drug called brentuximab vedotin at a lower dose than is FDA-approved.
Recruiting1 award Phase 2
More about Alison Moskowitz, MD
Clinical Trial Related8 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Alison Moskowitz, MD has experience with
- Pembrolizumab
- Ruxolitinib
- Duvelisib
- Gemcitabine
- Doxorubicin
- Entinostat
Breakdown of trials Alison Moskowitz, MD has run
Lymphoma
Relapse
Central Nervous System Hodgkin Lymphoma
Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alison Moskowitz, MD specialize in?
Alison Moskowitz, MD focuses on Lymphoma and Relapse. In particular, much of their work with Lymphoma has involved Stage I patients, or patients who are Stage III.
Is Alison Moskowitz, MD currently recruiting for clinical trials?
Yes, Alison Moskowitz, MD is currently recruiting for 6 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Alison Moskowitz, MD has studied deeply?
Yes, Alison Moskowitz, MD has studied treatments such as Pembrolizumab, Ruxolitinib, Duvelisib.
What is the best way to schedule an appointment with Alison Moskowitz, MD?
Apply for one of the trials that Alison Moskowitz, MD is conducting.
What is the office address of Alison Moskowitz, MD?
The office of Alison Moskowitz, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.